Potent antifungal activity of pure compounds from traditional Chinese medicine extracts against six oral candida species and the synergy with fluconazole against azole-resistant Candida albicans

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Yan, Zhimin ^a   Hua, Hong ^a   Xu, Yanying ^b   Samaranayake, Lakshman P ^c  

^a PEKING UNIVERSITY   (China)

^b NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALION; ANTIFUNGAL AGENT; FLUCONAZOLE; GENTIOPICRIN; PSEUDOLARIC ACID B; RHEIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CHINESE MEDICINE; CONTROLLED STUDY; DRUG POTENTIATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PICHIA GUILLIERMONDII; PRIORITY JOURNAL;

EID: 84863268234     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/106583     Document Type: Article

References (19)

1. Owotade F. J., Shiboski C. H., Poole L., Ramstead C. A., Malvin K., Hecht F. M., Greenspan J. S., Prevalence of oral disease among adults with primary HIV infection Oral Diseases 2008 14 6 497 499
2. Rhodus N. L., Bloomquist C., Liljemark W., Bereuter J., Prevalence, density, and manifestations of oral Candida albicans in patients with Sjogren's syndrome Journal of Otolaryngology 1997 26 5 300 305
3. Radfar L., Shea Y., Fischer S. H., Sankar V., Leakan R. A., Baum B. J., Pillemer S. R., Fungal load and candidiasis in Sjgren's syndrome Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 2003 96 3 283 287 (Pubitemid 37107443)
4. Ruhnke M., Eigler A., Tennagen I., Geiseler B., Engelmann E., Trautmann M., Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection Journal of Clinical Microbiology 1994 32 9 2092 2098 (Pubitemid 24258446)
5. Ruhnke M., Schmidt-Westhausen A., Morschhuser J., Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS Journal of Antimicrobial Chemotherapy 2000 46 2 291 295 (Pubitemid 30639302)
6. Pellati D., Fiore C., Armanini D., Rassu M., Bertoloni G., In vitro effects of glycyrrhetinic acid on the growth of clinical isolates of Candida albicans Phytotherapy Research 2009 23 4 572 574
7. Tomczykowa M., Tomczyk M., Jakoniuk P., Tryniszewska E., Antimicrobial and antifungal activities of the extracts and essential oils of Bidens tripartita Folia Histochemica et Cytobiologica 2008 46 3 389 393
8. Ferez C., Suarez C., Antifungal activity of plant extracts against Candida albicans American Journal of Chinese Medicine 1997 25 2 181 184 (Pubitemid 127758149)
9. National Committee for Clinical Laboratory Standards, Method for antifungal disk diffusion susceptibility testing of yeasts: approved guideline M44-A. National Committee for Clinical Laboratory Standards, Wayne, Pa, USA, 2004
10. National Committee for Clinical Laboratory Standards, Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa, USA, 2002
11. Liebowitz L. D., Ashbee H. R., Evans E. G. V., A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion Diagnostic Microbiology and Infectious Disease 2001 40 1-2 27 33 (Pubitemid 32614093)
12. Wenzel R. P., Gennings C., Bloodstream infections due to Candida species in the Intensive Care Unit: identifying especially high-risk patients to determine prevention strategies Clinical Infectious Diseases 2005 41 supplement 6 S389 S393 (Pubitemid 41266739)
13. Chiu P., Leung L. T., Ko B. C. B., Pseudolaric acids: isolation, bioactivity and synthetic studies Natural Product Reports 2010 27 7 1066 1083
14. Li E., Clark A. M., Hufford C. D., Antifungal evaluation of pseudolaric acid B, a major constituent of Pseudolarix kaempferi Journal of Natural Products 1995 58 1 57 67
15. Yang S. P., Dong L., Wang Y., Wu Y., Yue J. M., Antifungal diterpenoids of Pseudolarix kaempferi, and their structure-activity relationship study Bioorganic and Medicinal Chemistry 2003 11 21 4577 4584 (Pubitemid 37194262)
16. Xu J., Ramos A. R., Vilgalys R., Mitchell T. G., Clonal and spontaneous origins of fluconazole resistance in Candida albicans Journal of Clinical Microbiology 2000 38 3 1214 1220 (Pubitemid 30140588)
17. Cowen L. E., Sanglard D., Calabrese D., Sirjusingh C., Anderson J. B., Kohn L. M., Evolution of drug resistance in experimental populations of Candida albicans Journal of Bacteriology 2000 182 6 1515 1522 (Pubitemid 30121114)
18. Redding S., Smith J., Farinacci G., Rinaldi M., Fothergill A., Rhine-Chalberg J., Pfaller M., Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis Clinical Infectious Diseases 1994 18 2 240 242 (Pubitemid 24055265)
19. Revankar S. G., Dib O. P., Kirkpatrick W. R., McAtee R. K., Fothergill A. W., Rinaldi M. G., Redding S. W., Patterson T. F., Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients Clinical Infectious Diseases 1998 26 4 960 963 (Pubitemid 28180337)